SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1496.5512.8 (+0.86 %)
PREV CLOSE ( ) 1483.75
OPEN PRICE ( ) 1483.70
BID PRICE (QTY) 1496.65 (107)
OFFER PRICE (QTY) 1497.45 (32)
VOLUME 18735
TODAY'S LOW / HIGH ( )1479.50 1500.70
52 WK LOW / HIGH ( )922.55 1638.7
NSE1495.3010.65 (+0.72 %)
PREV CLOSE( ) 1484.65
OPEN PRICE ( ) 1484.65
BID PRICE (QTY) 1495.25 (46)
OFFER PRICE (QTY) 1495.45 (101)
VOLUME 1128899
TODAY'S LOW / HIGH( ) 1479.35 1495.80
52 WK LOW / HIGH ( )922.45 1638.85
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.